Access up-to-date information on prescription medications and drugs marketed in Peru. Search by product, laboratory, pathology, interactions, or pharmacological and therapeutic indices.
7.1.5
July 27, 2026
Novedades en el aplicativo: APLIXA ATEREZETIM 20/10 ATEREZETIM 40/10 BIOBRONCOL S CAVERLACTIN-PD COLIGAS FERBIZOL IMIPENEM + CILASTINA VITALIS LEVOZETALER LYRAFEM MACROFAST METILDOPA METILFENIDATO MORASS AMLO RESFRIOLITO SILOFOX SITAGLIP MET 50/850 SOLICARE SOLUDEX 5% TELMIDIPINO 40/5 TELMIDIPINO 80/5 VERTIGIREX VITATHON GRAGEA
MorePR Vademécum Perú 2026 is a mobile application that provides updated information on prescription medications and drugs marketed in Peru. It allows users to search for information through various indices like products, laboratories, pathologies, and drug interactions.
PR Vademécum Perú 2026 was developed by Clyna S.A. and is based on reliable sources such as drug manufacturers and current medical-pharmacological literature.
PR Vademécum Perú 2026 is available for iPhone, iPad, and iPod devices.
The latest version of PR Vademécum Perú 2026 is 7.1.4, which was last updated on March 15, 2026. This indicates a commitment to providing current information.
PR Vademécum Perú 2026 has an age rating of 17+, suggesting it is intended for adult users due to the nature of the medical information it contains.
PR Vademécum Perú 2026 is a paid application, with a price of $19.99.
No, PR Vademécum Perú 2026 does not contain advertisements. It is a paid application designed to provide an uninterrupted user experience.
No, PR Vademécum Perú 2026 is intended as a supplementary tool for healthcare professionals. It should not be used as a sole means for prescribing medications, and users should rely on their professional judgment.
